User:JonSDSUGrad/Sandbox/Demo dIGFBP1
From Wikipedia, the free encyclopedia
Insulin-like growth factor binding protein 1
|
||||||||||||||
PDB rendering based on 1zt3. | ||||||||||||||
Available structures: 1zt3, 1zt5, 2dsq | ||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | IGFBP1; IBP1; AFBP; IGF-BP25; PP12; hIGFBP-1 | |||||||||||||
External IDs | OMIM: 146730 MGI: 96436 HomoloGene: 498 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 3484 | 16006 | ||||||||||||
Ensembl | ENSG00000146678 | ENSMUSG00000020429 | ||||||||||||
Uniprot | P08833 | Q5SVY8 | ||||||||||||
Refseq | NM_000596 (mRNA) NP_000587 (protein) |
NM_008341 (mRNA) NP_032367 (protein) |
||||||||||||
Location | Chr 7: 45.89 - 45.9 Mb | Chr 11: 7.1 - 7.1 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Insulin-like growth factor binding protein 1, also known as IGFBP1, is a human gene.[1]
This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.[1]
[edit] References
[edit] Further reading
- Wood AW, Duan C, Bern HA (2005). "Insulin-like growth factor signaling in fish.". Int. Rev. Cytol. 243: 215-85. doi: . PMID 15797461.
- Firth SM, Baxter RC (2003). "Cellular actions of the insulin-like growth factor binding proteins.". Endocr. Rev. 23 (6): 824-54. PMID 12466191.
- Ferry RJ, Cerri RW, Cohen P (1999). "Insulin-like growth factor binding proteins: new proteins, new functions.". Horm. Res. 51 (2): 53-67. PMID 10352394.
- Rajaram S, Baylink DJ, Mohan S (1998). "Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.". Endocr. Rev. 18 (6): 801-31. PMID 9408744.
- Subramanian A, Sharma AK, Banerjee D, et al. (2007). "Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer.". Anticancer Res. 27 (5B): 3513-8. PMID 17972510.
- Li ZQ, Yu WP, Xie XD, et al. (2007). "Association of gastric cancer with tyrosine hydroxylase gene polymorphism in a northwestern Chinese population.". Clin. Exp. Med. 7 (3): 98-101. doi: . PMID 17972051.
- Pechlivanis S, Pardini B, Bermejo JL, et al. (2008). "Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.". Endocr. Relat. Cancer 14 (3): 733-40. doi: . PMID 17914103.
- Tworoger SS, Mantzoros C, Hankinson SE (2008). "Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels.". Obesity (Silver Spring) 15 (9): 2217-24. PMID 17890489.
- Berg U, Bang P, Carlsson-Skwirut C (2007). "Calpain proteolysis of insulin-like growth factor binding protein (IGFBP) -2 and -3, but not of IGFBP-1.". Biol. Chem. 388 (8): 859-63. doi: . PMID 17655506.
- Magne L, Blanc E, Marchand A, et al. (2008). "Stabilization of IGFBP-1 mRNA by ethanol in hepatoma cells involves the JNK pathway.". J. Hepatol. 47 (5): 691-8. doi: . PMID 17640761.
- Smith P, Nicholson LJ, Syed N, et al. (2007). "Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.". Clin. Cancer Res. 13 (14): 4061-8. doi: . PMID 17634530.
- Cheng I, DeLellis Henderson K, Haiman CA, et al. (2007). "Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.". J. Clin. Endocrinol. Metab. 92 (9): 3660-6. doi: . PMID 17566087.
- Oishi Y, Ohnishi M, Kobayashi-Hattori K, et al. (2007). "Cadmium cation increases the production and mRNA levels of insulin-like growth factor-binding protein-1 in HepG2.". Biosci. Biotechnol. Biochem. 71 (5): 1334-7. PMID 17485842.
- Sato Y, Chen Z, Miyazaki K (2007). "Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25.". Cancer Sci. 98 (7): 1055-63. doi: . PMID 17465992.
- Schweizer-Groyer G, Fallot G, Cadepond F, et al. (2007). "The cAMP-responsive unit of the human insulin-like growth factor-binding protein-1 coinstitutes a functional insulin-response element.". Ann. N. Y. Acad. Sci. 1091: 296-309. doi: . PMID 17341623.
- Tamimi RM, Cox DG, Kraft P, et al. (2007). "Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.". Breast Cancer Res. 9 (1): R18. doi: . PMID 17300730.
- Kaplan RC, McGinn AP, Pollak MN, et al. (2007). "Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.". J. Clin. Endocrinol. Metab. 92 (4): 1319-25. doi: . PMID 17264182.
- Chen C, Freeman R, Voigt LF, et al. (2007). "Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.". Cancer Epidemiol. Biomarkers Prev. 15 (12): 2461-6. doi: . PMID 17164371.
- Brady G, O'Regan E, Miller I, et al. (2007). "Serum levels of insulin-like growth factors (IGFs) and their binding proteins (IGFBPs), -1, -2, -3, in oral cancer.". International journal of oral and maxillofacial surgery 36 (3): 259-62. doi: . PMID 17113753.
- Degenhardt T, Matilainen M, Herzig KH, et al. (2007). "The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors.". J. Biol. Chem. 281 (51): 39607-19. doi: . PMID 17062566.